Publications
228
Citations
5,410
Est. group size
—
Recurring co-author estimate
Active years
43
Publishing since 1983
David Rosmarin conducts clinical research in dermatology, focusing on the treatment of inflammatory and pigmentary skin conditions such as vitiligo (loss of skin pigment), atopic dermatitis (eczema), and psoriasis. Much of the work involves clinical trials evaluating the effectiveness and safety of new medications, including topical creams and targeted immune-modulating drugs. The research aims to establish evidence for therapies that improve symptoms and quality of life for patients with chronic skin diseases.
Publication activity has grown substantially over the past decade, rising from single digits in 2017 to consistently high output in recent years (around 22 per year on average over the last five years).
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Typically publishes in teams of ~9 · 13% small-team papers (≤3 authors) · across 40 venues
- Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies
Dermatology and Therapy · 2025
- Measles resurgence: What every dermatologist should know
Journal of the American Academy of Dermatology · 2025
- Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials
Dermatology · 2025
- 63728 Increased risk of herpes infections in patients with atopic dermatitis who started a JAK-inhibitor vs. Th2 cytokine-inhibitor: a propensity-score matched claims data study
Journal of the American Academy of Dermatology · 2025
- REZPEGALDESLEUKIN, NOVEL TREG-INDUCING THERAPY, DEMONSTRATES EFFICACY IN ATOPIC DERMATITIS AND ASTHMA IN PHASE 2B TRIAL
Annals of Allergy Asthma & Immunology · 2025
- International multicenter case series of gestational dupilumab exposure in the treatment of atopic dermatitis: Maternal complications and fetal outcomes
Journal of the American Academy of Dermatology · 2025
- Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
Therapeutic Advances in Chronic Disease · 2025
- Tapinarof Cream 1% Once Daily: Consistent Efficacy Across All Body Regions, Including Head And Neck, In Adults And Children Down To 2 Years Of Age With Atopic Dermatitis
Journal of Allergy and Clinical Immunology · 2025
- 63617 Serious infections in patients with atopic dermatitis who started a JAK-inhibitor vs. cytokine-inhibitor: a nationwide propensity-score matched cohort study
Journal of the American Academy of Dermatology · 2025
- Assessment of vitiligo in clinical practice: a cross-sectional survey among experts
Journal of Dermatological Treatment · 2025
- Tapinarof Cream 1% Once Daily: Maintenance of Low Disease Activity Including Pruritus Through End of the Treatment-freeInterval in a Long-term Extension Trial in Patients Down to 2 Years of Age with Atopic Dermatitis
SKIN The Journal of Cutaneous Medicine · 2025
- Integrated Safety Analysis of Ruxolitinib Cream: Data From 20 Clinical Studies in Inflammatory Dermatologic Conditions
SKIN The Journal of Cutaneous Medicine · 2025
- Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks
American Journal of Clinical Dermatology · 2025
- Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with Vitiligo
Dermatology and Therapy · 2025
- A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis: An Expert Consensus Panel
Journal of Drugs in Dermatology · 2025
- Journal of the American Academy of Dermatology×58
- British Journal of Dermatology×25
- Journal of Investigative Dermatology×10
- Dermatology and Therapy×9
- Journal of the European Academy of Dermatology and Venereology×8
- Ranjitha Uppala
Medicine · University of Michigan
- Seitaro Nakagawa
Medicine · University of Michigan
- Leon Kircik
Medicine · Indiana University
- Tran Do
Medicine · University of Michigan
- Brian T. Cheng
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile